Effect of influenza vaccination on viral replication and immune response in persons infected with human immunodeficiency virus receiving potent antiretroviral therapy.
暂无分享,去创建一个
R. Haubrich | D. Richman | H. Günthard | D. Havlir | C. Spina | J. Wong | C. Ignacio | S. Kwok | H F Günthard | J K Wong | D D Richman | C A Spina | C Christopherson | C. Christopherson | J. Hwang | S Kwok | C Ignacio | J Hwang | R Haubrich | D Havlir | Jimmy Hwang
[1] S. Kwok,et al. Laboratory Markers of Antiviral Activity , 1998, Antiviral therapy.
[2] M. Pinkoski,et al. Changes in CD45 isoform expression vary according to the duration of T-cell memory after vaccination , 1995, Clinical and diagnostic laboratory immunology.
[3] C H Fox,et al. Effect of immunization with a common recall antigen on viral expression in patients infected with human immunodeficiency virus type 1. , 1996, The New England journal of medicine.
[4] N. Cox,et al. Influenza vaccination of human immunodeficiency virus (HIV)-infected adults: impact on plasma levels of HIV type 1 RNA and determinants of antibody response. , 1999, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[5] S. Hammer,et al. Changes in virologic markers as predictors of CD4 cell decline and progression of disease in human immunodeficiency virus type 1-infected adults treated with nucleosides. AIDS Clinical Trials Group Protocol 175 Team. , 1998, The Journal of infectious diseases.
[6] M. Dybul,et al. Effect of interleukin-2 on the pool of latently infected, resting CD4+ T cells in HIV-1-infected patients receiving highly active anti-retroviral therapy , 1999, Nature Medicine.
[7] R. Siliciano,et al. Viral Dynamics in HIV-1 Infection , 1998, Cell.
[8] J. Montaner,et al. A randomized, double-blind trial comparing combinations of nevirapine, didanosine, and zidovudine for HIV-infected patients: the INCAS Trial. Italy, The Netherlands, Canada and Australia Study. , 1998, JAMA.
[9] J. Sninsky,et al. Rapid and simple PCR assay for quantitation of human immunodeficiency virus type 1 RNA in plasma: application to acute retroviral infection , 1994, Journal of clinical microbiology.
[10] D. Richman,et al. Human Immunodeficiency Virus Replication and Genotypic Resistance in Blood and Lymph Nodes after a Year of Potent Antiretroviral Therapy , 1998, Journal of Virology.
[11] J. Lisziewicz,et al. Latent infection of CD4+ T cells provides a mechanism for lifelong persistence of HIV-1, even in patients on effective combination therapy , 1999, Nature Medicine.
[12] H. Kessler,et al. Immunologic and virologic evaluation after influenza vaccination of HIV‐1‐infected patients , 1997, AIDS.
[13] L. Haaheim,et al. Dynamics of HIV‐1 replication following influenza vaccination of HIV+ individuals , 1996, Clinical and experimental immunology.
[14] C. A. Macken,et al. Persistence of HIV-1 transcription in peripheral-blood mononuclear cells in patients receiving potent antiretroviral therapy. , 1999, The New England journal of medicine.
[15] D. Richman,et al. Recovery of replication-competent HIV despite prolonged suppression of plasma viremia. , 1997, Science.
[16] T. Elbeik,et al. Activation of virus replication after vaccination of HIV-1-infected individuals , 1995, The Journal of experimental medicine.
[17] A. Osterhaus,et al. Restored humoral immune response to influenza vaccination in HIV‐infected adults treated with highly active antiretroviral therapy , 1998, AIDS.
[18] J. Margolick,et al. The effect of influenza vaccination on human immunodeficiency virus type 1 load: a randomized, double-blind, placebo-controlled study. , 1996, The Journal of infectious diseases.
[19] A. Namazi,et al. Human immunodeficiency virus-type 1 replication can be increased in peripheral blood of seropositive patients after influenza vaccination , 1995 .
[20] L. Saravolatz,et al. Changes in plasma HIV RNA levels and CD4 cell counts after vaccination of pediatric patients , 1997, AIDS.
[21] M A Nowak,et al. Presence of an inducible HIV-1 latent reservoir during highly active antiretroviral therapy. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[22] A. Perelson,et al. Quantifying residual HIV-1 replication in patients receiving combination antiretroviral therapy. , 1999, The New England journal of medicine.
[23] A. Kaplan,et al. Effects of influenza vaccination in HIV-infected adults: a double-blind, placebo-controlled trial. , 1998, Vaccine.
[24] S. Suter,et al. Influenza immunization of HIV-1-infected patients does not increase HIV-1 viral load. , 1994, AIDS.
[25] B. Polk,et al. The influence of human immunodeficiency virus (HIV) infection on antibody responses to influenza vaccines. , 1988, Annals of internal medicine.
[26] M. Clerici,et al. Immunization with both T cell-dependent and T cell-independent vaccines augments HIV viral load secondarily to stimulation of tumor necrosis factor alpha. , 1998, AIDS research and human retroviruses.
[27] R Brookmeyer,et al. Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy. , 1997, Science.
[28] E. Lennette,et al. Diagnostic Procedures for Viral, Rickettsial and Chlamydial Infections , 1989 .